Abstract
There has been remarkable little progress in the management of patients with common solid tumors over the last 20 years. Surgery and radiotherapy have reached a peak of therapeutic effectiveness whilst the benefits of systemic treatment using drugs or hormones have reached a therapeutic plateau in tumors such as those of the breast, lung and colon. The reason for this is the lack of selectivity of currently available systemic agents. The closeness of the biochemical properties of tumor cells to their normal counterparts has made the successful development of anti-cancer agents an elusive quest.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Barratt, G. M., Ryman, B., Begent, R. H., Bagshawe, K. D., 1983, Improved radioimmunodetection of tumors using liposome entrapped antibody, Biochemica et Biophysica acta, 762:154.
Box, P. C, Berenstein, E. H., Siraganian, R. P., 1982, Techniques for enhancing the yield of antigen specific hybridomas in: “Hybridomas and Cancer Diagnosis and Treatment,” M.S. Mitchell and H.F. Oettgen, eds., Raven Press, New York.
Bradstock, K. F., Janossy, G., Bollom, F. J., Milstein, C., 1980, Anomolous phenotype in thymic acute lymphoblastic leukaemia, Nature, 284:455.
Brown, J. P., Woodbury, R. G., Hart, C. E., Hellstrom, I., Hellstrom, K. E., 1981, Quantitative analysis of melanoma associated antigen p97 in normal and neoplastic tissues, Proc.Nat.Acad. Sci., 78:539.
Chan, S., Evan, G., Ritson, A., Watson, J., Sikora, K., 1986, Radioimmunolocalization of the c-myc oncogene product in patients with cancer, Brit. J.Cancer., 54:761.
Curry, G. A., 1972, Eighty years of immunotherapy: A review of immunological methods used for the treatment of human cancer, Brit. J.Cancer., 26:141.
Cuttitta, F., Rosen, R., Gazdar, A. F., Minna, J. D., 1981, Monoclonal antibodies that demonstrate specificity for several types of human lung cancer, Proc.Nat.Acad. Sci., 78:4591.
Darras, ed., 1986, “Tumor Markers in Clinical Practice,” Blackwell, Oxford.
Dilman, R. O., Collins, H., Royston, I., 1982, T101 monoclonal antibody therapy in chronic lymphocytic leukaemia, in: “Hybridomas in Cancer Diagnosis and Treatment, pp. 151–157, M. S. Mitchell and H.F. Oettgen, eds., Raven Press, New York.
Dippold, W. G., Lloyd, K. O., Lucy, T. C., Old, L. J., 1980, Cell surface antigens of human malignant melanoma, Proc.Nat.Acad. Sci., 77:6114.
Embleton, M. J., Flannery, G. R., Baldwin, R. W., 1982, The effects of monoclonal antibody directed immunotoxins and immunomodulators on cultured osteogenic sarcoma cells, Brit. J.Cancer.
Finan, P. J., Ritson, A., Sikora, K., 1986, Monoclonal antibody immunoscintigraphy for the detection of primary colorectal cancers: a prospective study, Brit. J. of Surgery., 73:177.
Hurlyn, D., Steplewski, Z., Koprowski, H., 1979, Monoclonal antibodies in cell mediated cytotoxicity against human melanoma and colorectal carcinoma, Eur. J. of Immunol., 9:657.
Khaw, B. A., Gold, H. K., Yasuda, T., Haber, E., 1986, Scintigraphic quantification of myocardial necrosis in patients after intravenous injection of myosin-specific antibody, Circulation, 74:501.
Mach, J. P., Buchegger and Karrel, S., 1981, use of radiolabeled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photo-scanning and tomoscinti-scanning, Immunology Today., 239.
Miller, R. A., Levy, R., 1981a, Response of cutaneous T-cell lymphoma to therapy with hybridoma monoclonal antibody, Lancet, 2:226.
Miller, R. A., Levy, R., 1981b, In-vivo effects of murine hybridoma antibody in a patient with T-cell leukaemia, Blood, 58:78.
Miller, R. A., Muloney, D. G., Levy, R., 1982, Treatment of B-cell lymphoma with monoclonal anti-idiotype antibodies, New Engl.J. of Medicine, 306:517.
Nadler, L. M., Ritz, J., Griffin, J. D., Schlossman, S. F., 1983, Diagnosis and treatment of human leukaemias and lymphomas using monoclonal antibodies, Prog. in haematol., 46:187.
Nadler, L. M., Stashenko, P., Hardy, R., Schlossman, S. F., 1980, Serotherapy of a patient with a monoclonal antibody directed against a humanous, lymphoma associated antigen, Cancer Res., 40:3147.
Phillips, J., Alderson, T., Sikora, K., Watson, J. V., 1983, Localization of malignant glioma by radiolabelled monoclonal antibody, J. of Neurol., Neurosurg, Psychiatry, 46:388.
Ritz, J., Clavell, L. A., Schlossman, S. F., 1981, Serotherapy of acute lymphoblastic leukaemia with a monoclonal antibody, Blood 58:361.
Roberts, S., Cheetham, J. C, Reece, A. R., 1987, Generation of an antibody with enhanced affinity and specificity for its antigen by protein engineering, Nature, 328:731.
Ross, B., Langman, R., Trowbridge, I., Becker, R., 1983, Monoclonal antibodies and cancer, Academic Press, New York.
Sikora, K., Lennox, E. S., 1982, Tumor antigens in: “Clinical Aspects of Immunology,” P.J. Lachmann and D.K. Peters, eds., Blackwell, Oxford, pp.142–165.
Sikora, K., Alderson, T., Ellis, J., 1982, Human hybridomas from patients with malignant disease, Brit. J. of Cancer, 46:477.
Sikora, K., Wright, R., 1981, Human monoclonal antibodies to lung cancer antigens, Brit. J.Cancer, 43:696.
Sikora, K., Finan, T., Lennox, E., Smedley, H., 1983, The selection of monoclonal antibodies for the localization of colorectal cancer, Brit. J. Cancer, 47:253.
Sikora, K., Evan G., Steward, J., Watson, J., 1985, Detection of the c-myc oncogene product in testicular cancer, Br.J.Cancer, 52:171.
Sobol, R. E., Dillman, R. O., Royston, I., 1982, Phase 1 evaluation of immune monoclonal anti-melanoma antibody in man, in: “Hybridomas in Cancer Diagnosis and Treatment,” M. S. Mitchell and H.F. Oettgen, eds., Raven Press, New York.
Smedley, H., Finan, P., Sikora, K., 1983, Localization of metastatic carcinoma by radiolabelled monoclonal antibody, Brit. J.Cancer, 286:262.
Steward, J., Evan G., Watson, J., Sikora, K., 1986, Detection of the c-myc oncogene product in colonic polpys and carcinomas, Br.J.Cancer, 51:1.
Watson, J. V., Evan, G. I., Sikora, K., 1985, Quantitation of oncogene products in archival pathology material, J. Immunol. Methods., 83:170.
Thomas, E. D., Buckner, C. D., Fluornoy, N., 1977, One hundred patients with acute leukaemia treated by chemotherapy, total body irradiation and allogeneic bone marrow transplantation, Blood, 49:511.
Thorpe, P. E., Edwards, D. C, Ross, W. C. J., 1982, Monoclonal antibody toxin conjugates, in: “Monoclonal Antibodies in Clinical Medicine,” A.J. McMichael and J.W. Fabre, eds., Academic Press, London.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sikora, K. (1988). Monoclonal Antibodies in the Diagnosis and Treatment of Cancer. In: Hubbard, R., Marks, V. (eds) Clinical Applications of Monoclonal Antibodies. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1573-5_20
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1573-5_20
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8861-9
Online ISBN: 978-1-4613-1573-5
eBook Packages: Springer Book Archive